Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

The interface between pre-marketing and post-marketing safety will be explored, with a focus on formal post-marketing risk management, primarily in the US and EU context. This session will encompass post-marketing risk assessment, Risk Management Plans (RMPs), and Risk Evaluation and Mitigation Strategies (REMS).